Last reviewed · How we verify

NCT06611982: GIFT

Guaranteed Income and Financial Treatment

Active, enrolled NA Last updated 25 March 2026
What this trial tests

NA trial testing Unconditional cash transfer in Cancer in 250 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
1 April 2023
Primary endpoint
30 July 2025
30 July 2026

Quick facts

Lead sponsorMeredith Doherty, PhD, LCSW
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment250
Start date1 April 2023
Primary completion30 July 2025
Estimated completion30 July 2026
Sites3 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Meredith Doherty, PhD, LCSW

Who can join

18 and older, any sex, with Cancer or Financial Hardship. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to learn if providing advanced cancer patients with $1000/month for 12 months will improve cancer outcomes. The main questions it aims to answer are: To what extent does receiving $1000/month additional income reduce financial hardship? To what extent does receiving $1000/month additional income improve quality of life? Does receiving $1000/month additional income improve survival outcomes? Participants will: Receive $1000/month for 12 months Complete a survey every 3 months for 12 months If selected, participate in semi-structured interviews about their financial behaviors

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Unconditional cash transfer

Trials testing the same drug.

Other recruiting trials for Cancer

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06611982.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing